Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Net Income towards Common Stockholders (2018 - 2024)

Avai Bio's Net Income towards Common Stockholders history spans 6 years, with the latest figure at -$4.8 million for Q1 2024.

  • For Q1 2024, Net Income towards Common Stockholders fell 738.05% year-over-year to -$4.8 million; the TTM value through Mar 2024 reached -$7.4 million, down 2031.53%, while the annual FY2025 figure was -$1.1 million, 61.63% up from the prior year.
  • Net Income towards Common Stockholders for Q1 2024 was -$4.8 million at Avai Bio, down from -$1.8 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $417163.0 in Q4 2020 and bottomed at -$4.8 million in Q1 2024.
  • The 4-year median for Net Income towards Common Stockholders is $21606.5 (2020), against an average of -$602864.7.
  • The largest annual shift saw Net Income towards Common Stockholders skyrocketed 4203.92% in 2020 before it crashed 1752.06% in 2023.
  • A 4-year view of Net Income towards Common Stockholders shows it stood at $417163.0 in 2020, then plummeted by 73.52% to $110471.0 in 2022, then plummeted by 1752.06% to -$1.8 million in 2023, then crashed by 163.09% to -$4.8 million in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Net Income towards Common Stockholders are -$4.8 million (Q1 2024), -$1.8 million (Q4 2023), and -$399621.0 (Q3 2023).